PRN Medicines Management

Dear Colleagues,

PRN stands for ‘pro re nata’ and is defined as authorising nurses to administer medications based on their discretion and by the patients’ requests as unscheduled medication administration alone or in combination with routine/regular prescriptions. It is used for medications prescribed by physicians and administered based on nurses’ judgements of patients’ needs and along with the collaboration of pharmacists. Accordingly, the safety of PRN medication practice depends of the expertise of and collaboration between nurses, physicians and pharmacists. Further, the significance of the patient’s role in the appropriate use of PRN medications should be emphasised.

PRN medicins management has many benefits, but its inappropriate use can lead to overdose and overuse of medications and endangering patient safety. Therefore, there is a need for improvement of current international knowledge and connection of researchers’ valuable practical experiences for the development of the safest model of PRN medicine management in various healthcare settings.

In this Special Issue, the editor welcomes qualitative and quantitative research articles, commentaries, letters to the editor, theoretical and methodological reviews on healthcare professionals’ experiences relating to PRN medicines management consisting of prescription, administration and monitoring adverse drug reactions in short-term and long-term healthcare settings and acute care and emergency departments. The suggestion of innovative and practical strategies for improving the safety of PRN medication practice is emphasised.

Prof. Dr. Mojtaba Vaismoradi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.